{
    "doi": "https://doi.org/10.1182/blood-2019-124497",
    "article_title": "Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06 ",
    "article_date": "November 13, 2019",
    "session_type": "617.Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis",
    "abstract_text": "Introduction Patients with secondary acute myeloid leukemia (sAML) after myelodysplastic (MDS) or myeloproliferative neoplasms (MPN) treated with chemotherapy show poorer outcomes compared with de novo AML; consequently, these cases should be allocated to allogeneic stem cell transplant (alloSCT) whenever possible (D\u00f6hner H, Blood 2017). Some recent evidence suggested the potential of molecular characterization for implementing the current WHO definition (Arber DA, Blood 2016), since chromatin-splicing mutations have been reported to be highly specific for sAML (Lindsley RC, Blood 2015). However, this molecular signature has also been recognized in some clinically defined de novo AML cases (Papaemmanuil E, NEJM 2016). Based on this background, we assessed the clinical impact of chromatin-splicing mutational signature in clinically defined de novo AML patients enrolled into the prospective NILG 02/06 trial [ClinicalTrials.gov Identifier: NCT00495287]. Patients and Methods The trial (Bassan R, Blood Advances 2019) randomized 574 newly diagnosed AML patients to receive induction (standard vs high-dose) followed by consolidative chemotherapy and/or alloSCT. For the present analysis, only patients with de novo AML (n=313) and WHO-defined sAML after MDS or MPN (n=101) with a full genetic characterization have been considered. Studies performed at diagnosis included conventional karyotype (n=412) and molecular analysis (n=414) and/or targeted NGS (this latter performed on 197 patients with normal karyotype). Patients with WHO-sAML were defined by the presence of an antecedent history of MDS or MPN (n=21) and/or cytogenetic WHO criteria of AML with MDS-related changes (n=80). Chromatin-splicing mutational signature defined the molecular-sAML group and comprised ASXL1, STAG2, BCOR, KMT2A- PTD , EZH2, PHF6, SRSF2, SF3B1, U2AF1, ZRS2 and RUNX1 , excluding patients with WHO recurrent abnormalities. Results Chromatin-splicing mutations were scored in 55/313 (17.6%) de novo AML patients (hereafter named molecular-sAML). The most frequently reported were KMT2A -PTD (45.5%), RUNX1 (44.4%) and ASXL1 (22.2%), while other mutations in the signature accounted for 5-17.5% of cases. Compared to de novo AML without chromatin-splicing mutations, patients with molecular-sAML and WHO-sAML were older ( P <0.0001) and presented with lower white blood cell counts (WBC) ( P <0.0001). The 3 groups were balanced in regards to induction regimen ( P =0.5) and proportion of patients allocated to a consolidative alloSCT (31% in de novo AML, 30% in WHO-sAML and 33% in molecular-sAML, P =0.8). Complete remission (CR) after 1 or 2 induction cycles was achieved in 93% of de novo AML, 85% of molecular-sAML and 58% of WHO-sAML. In terms of 5-years overall survival (OS) and disease free survival (DFS), de novo AML patients did markedly better than both molecular and WHO-sAML patients (OS: 61%, P <0.0001; DFS: 54%, P <0.0009). Considering sAML patients, WHO-sAML had the worst OS when compared with molecular-sAML (18% vs 30%, P =0.02), but an overlapping DFS (22% vs 26%, P <0.3) (Figure 1). The negative impact of chromatin-splicing mutations was independently confirmed by multivariate analysis accounting for age, performance status, WBC and induction regimen [HR 2.2 (CI 95% 1.48-3.25), P =0.0001]. Among chromatin-splicing mutations, only RUNX1 and U2AF1 significantly affected OS [HR 3.55 (CI 95% 1.28-9.87), P =0.01 and HR 6.87 (CI 95% 1.71-27.55), P =0.006]. Finally, a consolidative alloSCT improved survival in all patients groups, most significantly in molecular and WHO-sAML (48% vs 24%, P =0.07 and 38% vs 8%, P =0.0001, respectively). Conclusions Chromatin-splicing mutational signature identifies a distinct high-risk group within de novo AML patients, which shows clinical characteristics and outcomes closer to sAML than to de novo AML patients. These data highlight the need to detect this molecular signature at diagnosis and support a molecular definition of sAML. View large Download slide View large Download slide  Close modal Disclosures Ferrero: Novartis: Honoraria. Corradini: Celgene: Honoraria, Other: Travel Costs; Gilead: Honoraria, Other: Travel Costs; Jazz Pharmaceutics: Honoraria; KiowaKirin: Honoraria; Kite: Honoraria; Novartis: Honoraria, Other: Travel Costs; Daiichi Sankyo: Honoraria; AbbVie: Consultancy, Honoraria, Other: Travel Costs; Amgen: Honoraria; Janssen: Honoraria, Other: Travel Costs; Roche: Honoraria; Sanofi: Honoraria; Servier: Honoraria; Takeda: Honoraria, Other: Travel Costs; BMS: Other: Travel Costs. Bassan: Incyte: Honoraria; Amgen Inc.: Honoraria; Pfizer: Honoraria; Shire: Honoraria. Rambaldi: Roche: Membership on an entity's Board of Directors or advisory committees, Other: travel support, Research Funding, Speakers Bureau; Omeros: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Jazz: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau, travel support.",
    "topics": [
        "chromatin",
        "italy",
        "leukemia",
        "leukemia, secondary acute",
        "rna splicing",
        "chemotherapy regimen",
        "karyotype determination procedure",
        "allogeneic stem cell transplant",
        "complete remission",
        "massively-parallel genome sequencing"
    ],
    "author_names": [
        "Chiara Caprioli, MD",
        "Federico Lussana, MD",
        "Silvia Salmoiraghi, BioSc",
        "Roberta Cavagna, BioSc",
        "Ksenija Buklijas, BioSc",
        "Lara Elidi, BioSc",
        "Pamela Zangh\u00ec, BioSc",
        "Anna Michelato, PhD",
        "Federica Delaini, MSc",
        "Elena Oldani, MSc",
        "Dario Ferrero, MD",
        "Ernesta Audisio, MD",
        "Filippo Marmont, MD",
        "Elisabetta Terruzzi, MD",
        "Lorella De Paoli, MD",
        "Chiara Cattaneo, MD",
        "Erika Borlenghi, MD",
        "Irene Cavattoni, MD",
        "Monica Tajana, MD",
        "Anna Maria Scattolin, MD",
        "Daniele Giovanni Mattei, MD",
        "Paolo Corradini",
        "Leonardo Campiotti, MD",
        "Fabio Ciceri, MD",
        "Massimo Bernardi, MD",
        "Elisabetta Todisco, MD PhD",
        "Agostino Cortelezzi, MD",
        "Sergio Cortelazzo, MD",
        "Giacomo Gianfaldoni, MD",
        "Alberto Bosi, MD",
        "Brunangelo Falini, MD PhD",
        "Tamara Intermesoli, MD",
        "Chiara Pavoni, Statistician",
        "Renato Bassan, MD",
        "Orietta Spinelli, PhD",
        "Alessandro Rambaldi, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Chiara Caprioli, MD",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Federico Lussana, MD",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Silvia Salmoiraghi, BioSc",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roberta Cavagna, BioSc",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ksenija Buklijas, BioSc",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lara Elidi, BioSc",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pamela Zangh\u00ec, BioSc",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Michelato, PhD",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Federica Delaini, MSc",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elena Oldani, MSc",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Dario Ferrero, MD",
            "author_affiliations": [
                "Hematology Department, University of Turin, Turin, Italy "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ernesta Audisio, MD",
            "author_affiliations": [
                "AOU Citt\u00e0 della Salute e della Scienza, Torino, Italy "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Filippo Marmont, MD",
            "author_affiliations": [
                "AOU Citt\u00e0 della Salute e della Scienza, Torino, Italy "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisabetta Terruzzi, MD",
            "author_affiliations": [
                "Azienda Ospedaliera San Gerardo, Monza, Italy "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lorella De Paoli, MD",
            "author_affiliations": [
                "Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Chiara Cattaneo, MD",
            "author_affiliations": [
                "ASST Spedali Civili, Brescia, Italy "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Erika Borlenghi, MD",
            "author_affiliations": [
                "ASST Spedali Civili, Brescia, Italy "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Irene Cavattoni, MD",
            "author_affiliations": [
                "General Hospital of Bolzano, Bolzano, Italy "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Tajana, MD",
            "author_affiliations": [
                "ASST Ospedale di Cremona, Cremona, Italy "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Maria Scattolin, MD",
            "author_affiliations": [
                "Ospedale dell'Angelo e SS. Giovanni e Paolo, Venezia Mestre, Italy "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniele Giovanni Mattei, MD",
            "author_affiliations": [
                "Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo Corradini",
            "author_affiliations": [
                "Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Milan, Italy "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Leonardo Campiotti, MD",
            "author_affiliations": [
                "Universit\u00e0 Insubria, Varese, Italy "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabio Ciceri, MD",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimo Bernardi, MD",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisabetta Todisco, MD PhD",
            "author_affiliations": [
                "European Institute of Oncology, Milano, Italy "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Agostino Cortelezzi, MD",
            "author_affiliations": [
                "Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sergio Cortelazzo, MD",
            "author_affiliations": [
                "Clinica Humanitas/Gavazzeni, Bergamo, Italy "
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giacomo Gianfaldoni, MD",
            "author_affiliations": [
                "AOU Careggi, Firenze, Italy "
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alberto Bosi, MD",
            "author_affiliations": [
                "AOU Careggi, Firenze, Italy "
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Brunangelo Falini, MD PhD",
            "author_affiliations": [
                "Universit\u00e0 di Perugia, Perugia, Italy "
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Tamara Intermesoli, MD",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Chiara Pavoni, Statistician",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Renato Bassan, MD",
            "author_affiliations": [
                "Ospedale dell'Angelo e SS. Giovanni e Paolo, Venezia Mestre, Italy "
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Orietta Spinelli, PhD",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandro Rambaldi, MD",
            "author_affiliations": [
                "Onco-Hematology Department, Universit\u00e0 degli Studi di Milano, Milano, Italy ",
                "University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy"
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-18T09:33:01",
    "is_scraped": "1"
}